"The data suggest a common evolutionary origin for both inhibitory mechanisms called decay acceleration and cofactor activity with variable C3b binding through domains at sites ii iii and iv and provide a framework for understanding regulators of complement activation (RCA) disease-related mutations and immune evasion."xsd:string